Anabel Granja DomĆnguez is a physiotherapist and researcher specializing in multiple sclerosis and healthcare technology assessment. With a degree in Physiotherapy from the University of Seville, she has worked in research roles at the Hospital Universitario Virgen Macarena and FundaciĆ³n DINAC, contributing to clinical trials, European projects, and scientific dissemination. Currently, she is a researcher at the Agencia de EvaluaciĆ³n de TecnologĆas Sanitarias de AndalucĆa, focusing on European-funded projects. She holds a Master’s in Motor Neurocontrol and has pursued doctoral studies in clinical procedures and health outcomes. Her work emphasizes innovation in healthcare evaluation and neurological disease management.
Profile
Orcid
Early Academic Pursuits š
Anabel Granja Dominguez embarked on her academic journey in physiotherapy at the University of Seville, where she earned her degree between 2010 and 2014. This foundational education provided her with a strong understanding of human movement and rehabilitation, shaping her early interest in neurological conditions and their treatment. To further deepen her expertise, she pursued a Masterās degree in Neurocontrol Motor at Universidad Rey Juan Carlos, completing it in December 2017. This postgraduate study refined her skills in motor control, neurological rehabilitation, and therapeutic strategies, setting the stage for her specialized research work in multiple sclerosis and related neurological disorders.
Additionally, Anabel enrolled in a doctoral program at the University of Seville, focusing on clinical procedures, interventions, and health outcomes. Her educational journey also included a postgraduate course in the evaluation of medications and health technologies at the Universidad Nacional de EducaciĆ³n a Distancia, further broadening her knowledge in health sciences assessment and regulatory frameworks.
Professional Endeavors š
Anabel’s professional career commenced in May 2015 when she joined the AsociaciĆ³n ELA AndalucĆa as a physiotherapist. Her passion for neurological disorders soon led her to the Hospital Universitario Virgen Macarena, where she worked in the multiple sclerosis research unit from September 2015 to 2018. Initially employed through Neuroinvest and later through Fisevi, she played a pivotal role in clinical trials, scientific publications, and international research collaborations.
From May 2018 to January 2023, she expanded her impact at FundaciĆ³n DINAC, where she served as a researcher, sub-investigator, evaluator, and coordinator of clinical trials focusing on multiple sclerosis. Her responsibilities included managing scientific events, coordinating international projects, and disseminating research findings through conferences and seminars.
Currently, Anabel is an investigator at the Agencia de EvaluaciĆ³n de TecnologĆas Sanitarias de AndalucĆa (AETSA), FundaciĆ³n Progreso y Salud, where she contributes to European Commission-funded projects. Her most recent work involves developing and publishing a methodological manual for clinical practice guidelines, reinforcing her commitment to evidence-based medicine and healthcare improvement.
Contributions and Research Focus š
Anabelās research has primarily focused on multiple sclerosis, its rehabilitation strategies, and clinical trial methodologies. Her extensive involvement in research projects has led to notable contributions in the evaluation of neurological disorders, patient-centered therapeutic interventions, and the improvement of clinical trial protocols. She has authored and co-authored several scientific publications, actively participated in international conferences, and contributed to the development of best practices in neurological rehabilitation.
Her expertise extends beyond research, as she has been instrumental in organizing scientific events, coordinating multicenter trials, and fostering interdisciplinary collaboration in the medical community.
Accolades and Recognition š
Throughout her career, Anabel has gained recognition for her dedication to neurological research and healthcare evaluation. Her work in multiple sclerosis research has been acknowledged through her contributions to European projects and international collaborations. Her role in developing clinical practice guidelines further exemplifies her influence in shaping healthcare policies and treatment frameworks.
Her expertise and leadership in clinical trials and healthcare evaluation have made her a respected figure in the medical research community, with colleagues and institutions valuing her contributions to evidence-based medicine.
Publication Top Notes